Resultados de la búsqueda 751-760 of 12038 for ocd

  1. Neurología - Ensayos clínicos - Mayo Clinic

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing neurocognitive ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to design, develop and assess the performance characteristics of NGS assays using circulating tumor DNA for the detection of ...

  3. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to evaluate whether primary palliative care is an alternative strategy to specialty palliative care for improving ...

  4. Oncología (médica) - Ensayos clínicos

    A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  6. Oncología (médica) - Ensayos clínicos

    This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

  7. Oncología (médica) - Ensayos clínicos

    Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...

  8. Neurología - Ensayos clínicos

    We aim to determine whether cognitive impairment attributable to cerebral hemodynamic impairment in patients with high-grade asymptomatic carotid artery ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...

  10. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...